Nanobiotix
NBTX
12 hedge funds and large institutions have $59.7M invested in Nanobiotix in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.07% more ownership
Funds ownership: 19.67% → 19.75% (+0.07%)
0% more funds holding
Funds holding: 12 → 12 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
11% less capital invested
Capital invested by funds: $67.5M → $59.7M (-$7.75M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$247K |
| 2 |
GI
GAMMA Investing
Foster City,
California
|
+$6.89K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.18K |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.95K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$856 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citigroup
New York
|
-$4.62K |
| 2 |
Morgan Stanley
New York
|
-$4.26K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.92K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JJ
1
Johnson & Johnson
New Brunswick,
New Jersey
| $36.6M | – | – | – |
|
2
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $17.9M | – | – | – |
|
|
PA
3
Perceptive Advisors
New York
| $3.61M | – | – | – |
|
|
4
BlackRock
New York
| $1.65M | +$247K | +34,939 | +16% |
|
5
UBS Group
Zurich,
Switzerland
| $20.1K | – | – | – |
|
|
GI
6
GAMMA Investing
Foster City,
California
| $7.47K | +$6.89K | +975 | +557% |
|
|
7
Qube Research & Technologies (QRT)
London,
United Kingdom
| $3.86K | +$1.95K | +276 | +80% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $2.92K | +$3.18K | +450 | New |
|
|
9
Bank of America
Charlotte,
North Carolina
| $1.7K | +$856 | +121 | +86% |
|
10
RhumbLine Advisers
Boston,
Massachusetts
| $205 | – | – | – |
|
|
11
Morgan Stanley
New York
| $13 | -$4.26K | -602 | -100% |
|
|
12
Citigroup
New York
| – | -$4.62K | -635 | Closed |
|
|
13
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1.92K | -271 | -89% |
|
NBTX Hedge Fund Activity: Q1 2024 in Review
12 of the 6,946 institutional investors tracked by Wall St. Rank reported a position in Nanobiotix (NBTX) for Q1 2024, worth a combined $59.7M — down 11% from $67.5M a quarter earlier.
Fund positioning in NBTX was balanced in Q1 2024: 1 fund opened new positions, 1 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, adding an estimated $247K. The largest seller was Citigroup, exiting entirely with an estimated $4.62K sold.
- 12 institutional investors held Nanobiotix (NBTX) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $59.7M of Nanobiotix stock for Q1 2024, down 11% quarter-over-quarter.
- 1 fund opened new Nanobiotix positions in Q1 2024 and 1 closed out, a net change of 0 holders.
- The largest Nanobiotix buyer in Q1 2024 was BlackRock, an estimated $247K added.
- The largest Nanobiotix seller in Q1 2024 was Citigroup, an estimated $4.62K sold.
Based on aggregated 13F filings for Q1 2024.